The prognostic role of hemoglobin, albumin, lymphocyte, and platelets score in peritoneal dialysis
International Urology and Nephrology · 2025
DOI: 10.1007/s11255-025-04679-9 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Urology and Nephrology, 2025. Verfasst von Xiaoyu Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Blood Purification Center, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Peritoneal Dialysis, Hemoglobins, Serum Albumin, Kidney Failure, Chronic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: the Changsha Municipal Natural Science Foundation, the Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
BACKGROUND: The Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) index serves as a novel composite biomarker reflecting both systemic inflammation and nutritional status in clinical practice. METHODS: This observational cohort study enrolled 892 peritoneal dialysis patients categorized by HALP quartiles (Q1-Q4). Through comprehensive survival analyses including Kaplan-Meier curves and multivariable Cox regression, we systematically evaluated the prognostic value of HALP for mortality outcomes. Predictive performance was rigorously assessed using time-dependent receiver operating characteristic analysis and net reclassification improvement metrics. RESULTS: The analysis revealed clinically significant findings where patients in the highest HALP quartile demonstrated markedly better survival outcomes compared to the lowest quartile, with hazard ratios of 0.43 (95% CI 0.21-0.86) for all-cause mortality and 0.23 (95% CI 0.08-0.69) for cardiovascular mortality. Importantly, incorporating HALP into prediction models yielded meaningful clinical improvements, elevating the 5-year mortality prediction accuracy from an AUC and achieving a statistically significant net reclassification improvement of 15%. CONCLUSIONS: These findings establish HALP as a practical and robust prognostic indicator in peritoneal dialysis patients that not only independently predicts mortality risk but also provides substantial incremental value beyond conventional risk factors, offering potential clinical utility for risk stratification and patient management decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Blood Purification Center, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
- Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
- Department of Nephrology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China.
- Department of Nephrology and Blood Purification Center, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China. liuyingh2002@csu.edu.cn.
Förderung
- the Changsha Municipal Natural Science Foundation
- the Natural Science Foundation of Hunan Province
Zitieren
APA
Guo, X., Song, P., Qian, Y., Zhuo, N., Fu, X., & Liu, Y. (2025). The prognostic role of hemoglobin, albumin, lymphocyte, and platelets score in peritoneal dialysis. International Urology and Nephrology. https://doi.org/10.1007/s11255-025-04679-9
Vancouver
Guo X, Song P, Qian Y, Zhuo N, Fu X, Liu Y. The prognostic role of hemoglobin, albumin, lymphocyte, and platelets score in peritoneal dialysis. International Urology and Nephrology. 2025. doi:10.1007/s11255-025-04679-9
BibTeX
@article{Guo2025,
author = {Guo, Xiaoyu and Song, Panai and Qian, Yijin and Zhuo, Ning and Fu, Xiaohui and Liu, Yinghong},
title = {The prognostic role of hemoglobin, albumin, lymphocyte, and platelets score in peritoneal dialysis},
journal = {International Urology and Nephrology},
year = {2025},
doi = {10.1007/s11255-025-04679-9}
}
EUVIMED